Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Videos
Oncology
20th March 2015
ESMO 2014: The collaboration between basic scientists and clinicians
At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, UK) discusses how the increased interaction between basic scientists, clinicians…
Oncology
20th March 2015
ESMO 2014: The TRACERx study of lung cancer
At ESMO 2014 Congress, Prof Charles Swanton (London Research Institute and UCL, UK) discusses TRAcking Cancer Evolution through therapy (TRACERx), which…
Oncology
20th March 2015
ESMO 2014: Tumour evolution and precision medicine
At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, London, UK) discusses how understanding the genetic changes in tumour evolution…
Oncology
20th March 2015
ESMO 2014: Tumour evolution and proactive clinical management
At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, London, UK) discusses how we can begin to anticipate tumour evolutionary…
Oncology
16th March 2015
ESMO 2014: The collaboration between UCL and the Francis Crick Institute
At ESMO 2014, Prof Jonathan Ledermann (UCL, UK) discusses the collaboration between UCL and the Francis Crick Institute that is hoped to increase the…
Oncology
16th March 2015
ESMO 2014: Inhibition of PARP, angiogenesis and immune checkpoints for ovarian cancer management
At ESMO 2014, Prof Jonathan Ledermann (University College London, UK) provides an update on the management of ovarian cancer, including maintenance…
Oncology
17th February 2015
ASH 2014: Phase II/III study of lenalidomide in relapsed/refractory diffuse large B-cell lymphoma
Dr Andrew Davies (University of Southampton, Southampton, UK) at the 2014 American Society of Hematology (ASH) Annual Meeting discusses a phase II/III…
Hematology
17th February 2015
Prof John Gribben and Prof Andre Goy at ASH 2014: Treating mantle cell lymphoma (Part 3)
Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Andre Goy (John Theurer Cancer Center, Hackensack, NJ) at the 2014 American Society…
Loading posts...
« Previous
1
…
80
81
82
83
84
Next »